Scarica l'app Stockscreener
391.45
3.30%
-13.36
Dopo l'orario di chiusura:
391.45
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché UTHR Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$404.81
Aprire:
$402.61
Volume 24 ore:
1.68M
Relative Volume:
2.46
Capitalizzazione di mercato:
$17.66B
Reddito:
$2.99B
Utile/perdita netta:
$1.21B
Rapporto P/E:
15.62
EPS:
25.06
Flusso di cassa netto:
$1.13B
1 W Prestazione:
+28.20%
1M Prestazione:
+33.02%
6M Prestazione:
+26.26%
1 anno Prestazione:
+11.08%
Intervallo 1D:
$385.01
$410.00
Intervallo di 1 settimana:
$302.19
$436.95
Portata 52W:
$266.98
$436.95
United Therapeutics Corp Stock (UTHR) Company Profile
Nome
United Therapeutics Corp
Settore
Telefono
(301) 608-9292
Indirizzo
1000 SPRING ST, SILVER SPRING, MD
Confronta UTHR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
391.45 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
|
ZTS
Zoetis Inc
|
152.43 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.15 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.89 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.76 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-07-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-02-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2022-12-06 | Iniziato | UBS | Buy |
| 2022-12-05 | Iniziato | Goldman | Sell |
| 2022-10-11 | Iniziato | Morgan Stanley | Overweight |
| 2022-09-20 | Reiterato | BofA Securities | Underperform |
| 2022-09-19 | Ripresa | Wedbush | Outperform |
| 2022-02-11 | Iniziato | BTIG Research | Neutral |
| 2021-07-14 | Aggiornamento | Argus | Hold → Buy |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-02-01 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-06-25 | Reiterato | H.C. Wainwright | Neutral |
| 2020-03-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-02-27 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-01-31 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-12-03 | Iniziato | BofA/Merrill | Underperform |
| 2019-08-01 | Aggiornamento | Jefferies | Underperform → Hold |
| 2019-08-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-09 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2018-08-08 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | Reiterato | Barclays | Underweight |
| 2018-01-18 | Ripresa | Credit Suisse | Underperform |
| 2017-12-27 | Reiterato | Wedbush | Outperform |
| 2017-04-27 | Reiterato | Wedbush | Outperform |
| 2017-03-30 | Iniziato | UBS | Sell |
| 2017-03-16 | Iniziato | Credit Suisse | Underperform |
Mostra tutto
United Therapeutics Corp Borsa (UTHR) Ultime notizie
Using Bollinger Bands to evaluate United Therapeutics Corporation2025 Dividend Review & Safe Capital Investment Plans - Newser
What’s next for United Therapeutics Corporation stock price2025 Growth vs Value & Daily Momentum Trading Reports - Newser
How hedge fund analytics apply to United Therapeutics Corporation stock2025 Bull vs Bear & Verified Entry Point Detection - Newser
United Therapeutics Corporation (NASDAQ:UTHR) Surges 38% Yet Its Low P/E Is No Reason For Excitement - simplywall.st
Detecting support and resistance levels for United Therapeutics Corporation2025 Technical Overview & Accurate Intraday Trade Tips - Newser
Mannkind Corporation shares rise 1.22% premarket after United Therapeutics' drug Tyvaso shows significant lung function improvement. - AInvest
Is United Therapeutics Corporation forming a bottoming baseJuly 2025 Pullbacks & Real-Time Chart Pattern Alerts - Newser
Does United Therapeutics Corporation show high probability of rebound2025 Big Picture & High Conviction Buy Zone Picks - Newser
Is United Therapeutics Corporation stock entering bullish territoryDividend Hike & Daily Entry Point Trade Alerts - Newser
Can machine learning forecast United Therapeutics Corporation recovery2025 Valuation Update & Long Hold Capital Preservation Tips - Newser
How to build a dashboard for United Therapeutics Corporation stockWall Street Watch & Daily Stock Trend Watchlist - Newser
Is United Therapeutics Corporation a turnaround storyMarket Risk Report & Expert Verified Movement Alerts - khodrobank.com
MannKind Lands A Price-Target Hike After Partner United Therapeutics Reports Strong Lung Drug Trial Results - Stocktwits
United Therapeutics Corporation’s volatility index tracking explainedPortfolio Growth Summary & Intraday High Probability Setup Alerts - Newser
United Therapeutics: On the Rise? - timothysykes.com
Why United Just Catapulted 39%, Pulling Two Rivals With It - Investor's Business Daily
United Therapeutics Shares Soar: Will Momentum Last? - StocksToTrade
Moving Averages: Is United Therapeutics Corporation stock influenced by commodity prices2025 Pullback Review & High Accuracy Swing Trade Signals - khodrobank.com
United Therapeutics Shares Surge on Strong Lung-Drug Trial Results - citybiz
United Therapeutics surges as Tyvaso succeeds in IPF trial: should you invest? - CryptoRank
United Therapeutics stock jumps as Jefferies raises price target on IPF study - Investing.com
United Therapeutics stock hits all-time high on successful drug trial - The Business Journals
UBS Lifts United Therapeutics’ Price Target to Drive Optimism - StocksToTrade
UBS Lifts United Therapeutics Price Target Amid Positive Study Results - timothysykes.com
Is United Therapeutics Corporation meeting your algorithmic filter criteriaWeekly Trend Report & Free Growth Oriented Trading Recommendations - Newser
United’s Tyvaso surprise in IPF potentially opens $4B market - BioWorld MedTech
Why Is United Therapeutics Stock Rallying On Tuesday?United Therapeutics (NASDAQ:UTHR) - Benzinga
United Therapeutics stock hits all-time high at $419.63 - Investing.com
United Therapeutics shares surge as lung disease drug meets main study goal - TradingView
PepsiCo, United Therapeutics Lead Market Cap Stock Movers on Tuesday - Investing.com
United Therapeutics shares surge after Tyvaso IPF trial hits key goal - MSN
United Therapeutics’ Stunning Leap: What’s Behind It? - StocksToTrade
United Therapeutics' TETON-2 Trial Shows Tyvaso Improves Lung Function In IPF Patients - Nasdaq
PepsiCo, Ionis Pharma, United Therapeutics - TradingView
United Therapeutics Corporation announces Teton-2 pivotal study of Tyvaso meets primary endpoint for the treatment of idiopathic pulmonary fibrosis - MarketScreener
United Therapeutics posts Tyvaso trial win (UTHR:NASDAQ) - Seeking Alpha
United Therapeutics Announces Positive TETON-2 Study Results - TipRanks
95.6mL Lung Function Improvement: United Therapeutics' Tyvaso Achieves Breakthrough in IPF Treatment Trial - Stock Titan
Does United Therapeutics Corporation have declining or rising EPS2025 Buyback Activity & Reliable Price Action Trade Plans - khodrobank.com
Published on: 2025-09-01 20:26:35 - Newser
Published on: 2025-09-01 19:48:53 - Newser
What is United Therapeutics Corporation’s valuation compared to sectorPortfolio Return Report & Weekly Market Pulse Alerts - khodrobank.com
Measuring United Therapeutics Corporation’s beta against major indicesJuly 2025 Review & Risk Controlled Swing Trade Alerts - Newser
United Therapeutics Corporation Rebound Backed by Sentiment Shift getLinesFromResByArray error: size == 0 - kangso.co.kr
Using flow based indicators on United Therapeutics CorporationQuarterly Growth Report & Fast Gain Swing Alerts - Newser
United Therapeutics Corporation Recovery Gathers Momentum on Chart Signals getLinesFromResByArray error: size == 0 - kangso.co.kr
Will United Therapeutics Corporation rebound enough to break evenWeekly Stock Report & Low Volatility Stock Recommendations - Newser
Tick level data insight on United Therapeutics Corporation volatilityBear Alert & Momentum Based Trading Ideas - Newser
Momentum divergence signals in United Therapeutics Corporation chart2025 Earnings Impact & Precise Swing Trade Alerts - Newser
Published on: 2025-08-31 13:32:31 - Newser
Candlestick signals on United Therapeutics Corporation stock todayDividend Hike & Safe Capital Growth Tips - Newser
United Therapeutics Corp Azioni (UTHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
4.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):